Science News
As hunt for sterile neutrino continues, mystery deepens
Phys.org - 8 Oct 2016 21:34
Physicists have hypothesized the existence of fundamental particles called sterile neutrinos for decades and a couple of experiments have even caught possible hints of them. However, according to new results from two maj...
True burden of head and neck cancer in France underestimated by more than one-third
Science Daily - 8 Oct 2016 19:48
A nationwide study of head and neck cancers in France has revealed that the true burden of the disease is underestimated by at least one-third, and that head and neck cancers carry a very high risk of secondary primary c...
70% of advanced cancer patients receive palliative care consultation at ESMO Designated Centers
Science Daily - 8 Oct 2016 19:48
Seven out of ten patients with advanced cancer receive a palliative care consultation at ESMO Designated Centres of Integrated Oncology and Palliative Care, according to survey results.
Phase I study of novel anti-cancer drug uses tumour mRNA expression to identify responders
Science Daily - 8 Oct 2016 19:48
The first-in-human dose escalation study of the pan-FGFR (fibroblast growth factor receptor) inhibitor BAY 1163877 in patients with treatment-refractory locally advanced or metastatic solid tumours were reported today at...
Ribociclib improves progression-free survival in advanced breast cancer
Science Daily - 8 Oct 2016 19:48
The addition of the CDK4/6 inhibitor ribociclib to letrozole therapy significantly improves progression-free survival in postmenopausal women with hormone receptor-positive advanced breast cancer, researchers report.
Targeting estrogen receptor improves progression-free survival in advanced breast cancer
Science Daily - 8 Oct 2016 19:48
Fulvestrant significantly increases progression-free survival in women with hormone-receptor-positive advanced breast cancer, particularly those with less aggressive lower-volume disease, researchers report.
Ipilimumab as adjuvant therapy improves overall survival in high risk stage III melanoma
Science Daily - 8 Oct 2016 19:48
Ipilimumab as adjuvant therapy significantly improves overall survival in patients with high risk stage III melanoma, according to the EORTC 18071 phase III trial results.
Immunotherapy shows promising results in first, second line treatment of metastatic bladder cancer
Science Daily - 8 Oct 2016 19:48
Immunotherapy has shown promising results in first and second line treatment of metastatic bladder cancer in two phase II trials.
Leprosy: Causes, Symptoms & Treatment
Live Science - 8 Oct 2016 18:55
Leprosy is a contagious, chronic disease, but if it is caught and treated quickly enough, the disease usually is not debilitating.
Hurricane Matthew Monitors Fly into the Belly of the Beast
Scientific American - 8 Oct 2016 13:00
NOAA storm scientists describe their harrowing trips into a swirling chaos of rain, dust, salt and bacteria --
Kids' consumption of high-calorie drinks at fast-food restaurants tied to combo meals
Science Daily - 8 Oct 2016 04:17
A new survey of children's and teenagers' eating habits at fast-food restaurants suggests that consumption levels of sugary drinks are closely tied to their automatic inclusion in "combo meal" packages.
Mystery of bacteria's antibiotic resistance unravelled
Science Daily - 8 Oct 2016 04:17
The first detailed biochemical characterization of a flavoenzyme involved in antibiotic resistance has now been revealed by scientists.
African-American, Hispanic men less likely to get treatment for prostate cancer, even with high-risk disease
Science Daily - 8 Oct 2016 04:17
African-American and Hispanic men in the United States are less likely to receive therapy for prostate cancer compared to Caucasian men -- even when they have more aggressive disease, according to new research.